# ARIPIPRAZOLE
> **ANDA216608** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2024-12-03
## Drug
- **FDA Application Number:** ANDA216608
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ARIPIPRAZOLE
- **Generic name:** Aripiprazole
- **Active ingredients:** ARIPIPRAZOLE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2024-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216608)
---
*MORVS · CC0 1.0*